Medical Horizons S.r.l., a leading distributor of artificial intelligence solutions for healthcare, announced an exclusive distribution agreement with Bowhead Health Inc., a Canadian innovator in secure health data management and AI-powered clinical trial matching. The partnership, announced on September 2, 2025, positions Medical Horizons as the exclusive partner for Bowhead Health across Italy, Turkey, and Cyprus, expanding access to advanced technologies designed to improve clinical trial recruitment and optimize research workflows.
Addressing Clinical Trial Recruitment Challenges
Healthcare systems worldwide are grappling with workforce shortages and rising clinical demands, making artificial intelligence an increasingly critical tool for hospitals and researchers seeking to deliver faster, more personalized care. Traditional clinical trial matching processes face significant limitations that impact patient access to potentially life-saving treatments.
"Manual clinical trial matching is slow, burdensome, and often misses the genomic details that matter most," said Francisco Diaz-Mitoma, CEO of Bowhead Health Inc. The company's platform addresses these inefficiencies by allowing hospitals to scan global and local trial databases instantly, helping connect patients with appropriate therapies far more efficiently than conventional methods.
Bowhead's AI-driven technology is designed to reduce time spent on manual searches, simplify workflows, and provide confidence for both researchers and patients, ultimately accelerating progress toward personalized medicine.
Strategic Expansion into European Markets
The partnership represents a significant expansion opportunity for both companies, with Medical Horizons leveraging its established presence in European healthcare markets to introduce Bowhead's innovative platform.
"This collaboration represents a decisive step in our strategy to deliver practical, high-impact AI solutions," said Guido Osti, CEO of Medical Horizons. "Bowhead Health has developed a unique platform that combines secure health data management, artificial intelligence, and clinical research. We are proud to guide their expansion in Italy, Turkey, and Cyprus."
Medical Horizons, headquartered in Florence, has established itself as Italy's leading distributor of AI healthcare technologies, with a proven track record of supporting hospitals in adopting next-generation solutions. The company has successfully introduced innovative AI platforms from companies including Tempus Pixel, Cortechs.ai, AZmed, and iCAD into the Italian healthcare ecosystem.
Technology Platform and Global Validation
Bowhead Health, based in Ottawa, Canada, has developed a comprehensive digital ecosystem that integrates multiple components designed to streamline clinical research processes. The platform features an AI-powered trial matching engine for personalized patient recruitment, a de-identified health data platform compliant with GDPR, HIPAA, and global security standards, and collaborative digital flows connecting patients, hospitals, researchers, and pharmaceutical companies.
The company is currently validating its technology with leading hospitals across Canada, Europe, India, and the United States, reporting strong early results from these validation efforts. This global approach to technology validation demonstrates the platform's potential scalability and adaptability across different healthcare systems and regulatory environments.
Medical Horizons provides comprehensive support services including market entry strategies, financial guidance, key opinion leader engagement, and ongoing customer support to ensure long-term adoption and impact. The company collaborates closely with institutions such as the Campus Bio-Medico University Hospital of Rome, demonstrating its deep integration within the Italian healthcare ecosystem.
